Triall announces that its first software solution ‘Verial eTMF’ has successfully passed the pilot stage and is now being onboarded and used in multiple clinical trial consortia. In summer 2019,...Read More
Triall today announces that it has officially partnered with Dizer Capital, a private equity firm focused on startups in the technology sector. The investment provided by Dizer Capital will enable...Read More
In part 1 and part 2 of this series, we explained how blockchain technology can be leveraged to enhance the integrity, auditability, and exchange of data in clinical trials. In this article, we will...Read More
In part 1 of this series, we explained how blockchain technology can be leveraged to enhance data integrity, auditability, and traceability in clinical trials. In this article, we dive into other unique...Read More
Allan Bukuya has joined the Triall initiative as Advisor eClinical Solutions. He brings two decades of experience in clinical research and in-depth understanding of the Pharma, CRO and eClinical industries....Read More
Danielle Bradbury will join the Triall initiative as advisor Quality and Compliance. She has over 20 years of experience in clinical research and has extensive knowledge of SOP management, GxP...Read More
Sina Djali will join the ranks of the Triall initiative as advisor Clinical Trial Data Analytics. Sina has over 25 years of experience in drug and clinical development in various...Read More
We are excited to announce the world’s first clinical trial on the blockchain. A beta version of the foundation’s Verial software application was given green light for use in a real-world...Read More
A steady and efficient influx of novel medical solutions is critical for meeting society’s current and future medical needs. The clinical research industry is responsible for the delivery of these...Read More
Triall today announces that it has received funding as part of the second Factom grant round of 2019. It will use these funds to develop a Factom-enabled Decentralized Identifier (DID)...Read More
